Hypertension prevalence, awareness, treatment, and control and predicted 10-year CVD risk: a cross-sectional study of seven communities in East and West Africa (SevenCEWA)

Okello, Samson; Muhihi, Alfa; Mohamed, Shukri F.; Ameh, Soter; Ochimana, Caleb; Oluwasanu, Abayomi Olabayo; Bolarinwa, Oladimeji Akeem; Sewankambo, Nelson; Danaei, Goodarz

doi:10.1186/s12889-020-09829-5

Table 4 Associations of hypertension prevalence, awareness, and treatment for all participants and by gender (adjusted odds ratios and 95% confidence interval), SevenCEWA study 2018

From: Hypertension prevalence, awareness, treatment, and control and predicted 10-year CVD risk: a cross-sectional study of seven communities in East and West Africa (SevenCEWA)

	Both genders				Women				Men
	Prevalence	Awareness	Treatment	Control	Prevalence	Awareness	Treatment	Control	Prevalence	Awareness	Treatment	Control
Number of participants (number with outcome) (%)	901 (25·4)	515 (57·2)	260 (50·5)	123 (47·3)	551 (25·7)	343 (62·3)	160 (46·6)	76 (47·5)	350 (25·0)	172 (49·1)	100 (58·1)	47 (47·0)
Age (each 10 yrs)	1·4 (1·4, 1·5)	1·2 (1·1, 1·3)	1·2 (1·1, 1·3)	0·7 (0·6, 0·8)	1·4 (1·3, 1·5)	1·2 (1·1, 1·3)	1·2 (1·0, 1·4)	0·7 (0·6, 0·9)	1·5 (1·3, 1·6)	1·2 (1·1, 1·4)	1·1 (0·9, 1·3)	0·6 (0·5, 0·8)
Level of Education
None	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref
Primary	0·6 (0·5, 0·8)	0·5 (0·3, 0·7)	0·6 (0·4, 0·9)	0·4 (0·2, 1·0)	0·6 (0·4, 0·7)	0·4 (0·3, 0·6)	0·5 (0·3, 0·8)	0·5 (0·2, 1·1)	0·7 (0·4, 1·2)	0·5 (0·3, 1·1)	0·9 (0·4, 2·3)	0·3 (0·1, 1·1)
Secondary	0·6 (0·4, 0·8)	0·7 (0·5, 1·0)	1·0 (0·6, 1·6)	0·4 (0·2, 0·9)	0·6 (0·4, 0·9)	0·7 (0·4, 1·1)	0·9 (0·5, 1·7)	0·4 (0·2, 0·9)	0·6 (0·4, 1·1)	0·6 (0·3, 1·3)	1·2 (0·5, 3·0)	0·5 (0·1, 2·1)
Tertiary	0·7 (0·5, 0·9)	0·8 (0·5, 1·2)	1·0 (0·6, 1·8)	0·3 (0·1, 0·6)	0·6 (0·4, 0·8)	0·8 (0·5, 1·4)	1·5 (0·7, 3·1)	0·3 (0·1, 0·9)	0·9 (0·5, 1·6)	0·7 (0·3, 1·6)	0·8 (0·3, 2·2)	0·2 (0·1, 1·3)
Wealth index
Poorest	0·8 (0·7, 1·1)	0·7 (0·5, 1·0)	1·1 (0·7, 1·7)	1·4 (1·7, 2·7)	0·9 (0·7, 1·3)	0·8 (0·5, 1·2)	1·1 (0·6, 1·9)	0·9 (0·4, 2·1)	0·7 (0·5, 1·1)	0·6 (0·3, 1·1)	1·0 (0·5, 2·2)	3·5 (1·0, 12·9)
Poor	0·9 (0·7, 1·1)	0·9 (0·6, 1·2)	0·8 (0·5, 1·4)	1·1 (0·5, 2·5)	1·0 (0·7, 1·3)	0·9 (0·6, 1·4)	0·6 (0·3, 1·1)	1·2 (0·5, 3·0)	0·7 (0·5, 1·0)	0·8 (0·5, 1·5)	1·7 (0·8, 3·8)	1·1 (0·2, 4·7)
Fair	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref
Rich	0·8 (0·7, 1·1)	0·8 (0·6, 1·2)	0·9 (0·6, 1·5)	1·2 (0·5, 2·5)	0·7 (0·5, 1·0)	0·8 (0·5, 1·3)	0·7 (0·3, 1·3)	0·7 (0·3, 2·0)	1·0 (0·7, 1·4)	0·8 (0·4, 1·4)	1·5 (0·7, 3·1)	1·7 (0·4, 6·9)
Richest	0·9 (0·7, 1·2)	0·9 (0·6 1·3)	1·0 (0·6, 1·6)	1·4 (0·6, 3·0)	0·8 (0·5, 1·1)	0·8 (0·5, 1·4)	0·8 (0·4, 1·6)	1·2 (0·5, 3·2)	1·1 (0·8, 1·6)	0·9 (0·5, 1·5)	1·3 (0·6, 2·8)	1·6 (0·4, 6·6)
Health Insurance
Uninsured	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref	Ref
Insured	0·6 (0·5, 0·8)	0·8 (0·6, 1·1)	1·6 (1·4, 1·9)	0·7 (0·4, 1·5)	0·7 (0·5, 0·9)	0·9 (0·5, 1·4)	1·5 (1·2, 1·9)	0·8 (0·3, 2·1)	0·6 (0·4, 0·8)	0·7 (0·4, 1·2)	0·8 (0·4, 1·6)	0·6 (0·2, 1·7)

^aAdjustment was done for study site and gender

Back to article page

ISSN: 1471-2458

Contact us

Submission enquiries: bmcpublichealth@biomedcentral.com
General enquiries: ORSupport@springernature.com

BMC Public Health

Contact us